The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions
Open accessAbstract
Host-microbiota interactions involving inflammatory and metabolic pathways have been linked to the pathogenesis of multiple immune-mediated diseases and metabolic conditions like diabetes and obesity. Accumulating evidence suggests that alterations in the gut microbiome could play a role in cardiovascular disease. This review focuses on recent advances in our understanding of the interplay between diet, gut microbiota and cardiovascular disease, with emphasis on heart failure and coronary artery disease. Whereas much of the literature has focused on the circulating levels of the diet- and microbiota-dependent metabolite trimethylamine-N-oxide (TMAO), several recent sequencing-based studies have demonstrated compositional and functional alterations in the gut microbiomes in both diseases. Some microbiota characteristics are consistent across several study cohorts, such as a decreased abundance of microbes with capacity for producing butyrate. However, the published gut microbiota studies generally lack essential covariates like diet and clinical data, are too small to capture the substantial variation in the gut microbiome, and lack parallel plasma samples, limiting the ability to translate the functional capacity of the gut microbiomes to actual function reflected by circulating microbiota-related metabolites. This review attempts to give directions for future studies in order to demonstrate clinical utility of the gut-heart axis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences
Langille, M. G. I., Zaneveld, J., Caporaso, J. G., McDonald, D., Knights, D., Reyes, J. A., Clemente, J. C., Burkepile, D. E., Vega Thurber, R. L., Knight, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2676 · Cited by 9,116
Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Kozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K., & Schloss, P. D. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.01043-13 · Cited by 7,112
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., et al. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.75 · Cited by 5,634
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597 · cited 4×
“More than just a marker of the disease, TMAO is potentially a causative agent in atherosclerosis [29].”
BackgroundInfluentialCommensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
Roth, G. A., Johnson, C., Abajobir, A., Abd-Allah, F., Abera, S. F., Abyu, G., Ahmed, M., Aksut, B., Alam, T., Alam, K., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.052 · Cited by 3,791
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Human Genetics Shape the Gut Microbiome
Goodrich, J. K., Waters, J. L., Poole, A. C., Sutter, J. L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J. T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.053 · Cited by 3,164 · cited 1×
“Host genetic factors have a small but significant impact on the composition of the gut microbiota [69,70].”
BackgroundPersonalized nutrition by prediction of glycemic responses
Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.001 · Cited by 2,929
Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
Environment dominates over host genetics in shaping human gut microbiota
Rothschild, D., Weissbrod, O., Barkan, E., Kurilshikov, A., Korem, T., Zeevi, D., Costea, P. I., Godneva, A., Kalka, I. N., Bar, N., et al. (2018) · Nature · doi:10.1038/nature25973 · Cited by 2,859 · cited 1×
“However, environmental factors probably play a greater role [71].”
BackgroundDiet–microbiota interactions as moderators of human metabolism
Sonnenburg, J. L., & Bäckhed, F. (2016) · Nature · doi:10.1038/nature18846 · Cited by 2,257
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220 · cited 1×
“Whereas bile acids are traditionally regarded as emulsifiers to facilitate the absorption of dietary fat and fat-soluble vitamins, bile acids are now recognized as signaling molecules that interact with plasma membranes as well as nuclear receptors, exerting regulatory effects on glucose and lipid metabolism [57], ene…”
BackgroundGut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
Zhernakova, A., Kurilshikov, A., Bonder, M. J., Tigchelaar, E. F., Schirmer, M., Vatanen, T., Mujagic, Z., Vila, A. V., Falony, G., Vieira-Silva, S., et al. (2016) · Science · doi:10.1126/science.aad3369 · Cited by 1,914
Extensive impact of non-antibiotic drugs on human gut bacteria
Maier, L., Pruteanu, M., Kuhn, M., Zeller, G., Telzerow, A., Anderson, E. E., Brochado, A. R., Fernandez, K. C., Dose, H., Mori, H., et al. (2018) · Nature · doi:10.1038/nature25979 · Cited by 1,905 · cited 1×
“An interesting in vitro study examined nearly 1000 different drugs, finding that an estimated 24% of the drugs, most of which were not antibiotics, had the ability to suppress the growth of at least one commensal microbe in cultures [73].”
BackgroundFadrosh, D. W., Ma, B., Gajer, P., Sengamalay, N., Ott, S., Brotman, R. M., & Ravel, J. (2014) · Microbiome · doi:10.1186/2049-2618-2-6 · Cited by 1,698
De Filippis, F., Pellegrini, N., Vannini, L., Jeffery, I. B., La Storia, A., Laghi, L., Serrazanetti, D. I., Di Cagno, R., Ferrocino, I., Lazzi, C., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309957 · Cited by 1,638
The gut microbiome in atherosclerotic cardiovascular disease
Jie, Z., Xia, H., Zhong, S.-L., Feng, Q., Li, S., Liang, S., Zhong, H., Liu, Z., Gao, Y., Zhao, H., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00900-1 · Cited by 1,638
Wu, H., Esteve, E., Tremaroli, V., Khan, M. T., Caesar, R., Mannerås-Holm, L., Ståhlman, M., Olsson, L. M., Serino, M., Planas-Fèlix, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4345 · Cited by 1,632
Bile acids: regulation of synthesis
Chiang, J. Y. L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900010-jlr200 · Cited by 1,515
Symptomatic atherosclerosis is associated with an altered gut metagenome
Karlsson, F. H., Fåk, F., Nookaew, I., Tremaroli, V., Fagerberg, B., Petranovic, D., Bäckhed, F., & Nielsen, J. (2012) · Nature Communications · doi:10.1038/ncomms2266 · Cited by 1,371 · cited 3×
“reporting decreased relative abundance of Roseburia and Eubacterium, known producers of butyrate [18].”
InfluentialWang, Z., Roberts, A. B., Buffa, J. A., Levison, B. S., Zhu, W., Org, E., Gu, X., Huang, Y., Zamanian-Daryoush, M., Culley, M. K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.055 · Cited by 1,317
Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans
Vatanen, T., Kostic, A. D., d’Hennezel, E., Siljander, H., Franzosa, E. A., Yassour, M., Kolde, R., Vlamakis, H., Arthur, T. D., Hämäläinen, A.-M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.007 · Cited by 1,289 · cited 1×
“Recent work has demonstrated different bioactivity of LPS, with hexa-acylated, but no penta-acylated LPS triggering inflammation [26,27].”
BackgroundDrug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y.-B., & Hohmann, E. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910437 · Cited by 1,281
Tang, W. H. W., Wang, Z., Kennedy, D. J., Wu, Y., Buffa, J. A., Agatisa-Boyle, B., Li, X. S., Levison, B. S., & Hazen, S. L. (2015) · Circulation Research · doi:10.1161/circresaha.116.305360 · Cited by 1,223
Utilization of Nutrients by Isolated Epithelial Cells of the Rat Colon
Roediger, W. E. W. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80339-9 · Cited by 1,191
Marques, F. Z., Nelson, E., Chu, P.-Y., Horlock, D., Fiedler, A., Ziemann, M., Tan, J. K., Kuruppu, S., Rajapakse, N. W., El-Osta, A., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024545 · Cited by 1,065
Kootte, R. S., Levin, E., Salojärvi, J., Smits, L. P., Hartstra, A. V., Udayappan, S. D., Hermes, G., Bouter, K. E., Koopen, A. M., Holst, J. J., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.09.008 · Cited by 1,039 · cited 1×
“FMT from lean donors was previously shown to normalize insulin sensitivity in obese subjects with the metabolic syndrome [98,99], although the effect was only temporary.”
BackgroundRole of gut microbiota-generated short-chain fatty acids in metabolic and cardiovascular health
Chambers, E. S., Preston, T., Frost, G., & Morrison, D. J. (2018) · Current Nutrition Reports · doi:10.1007/s13668-018-0248-8 · Cited by 691
Tang, W. H. W., Wang, Z., Fan, Y., Levison, B., Hazen, J. E., Donahue, L. M., Wu, Y., & Hazen, S. L. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.617 · Cited by 681
Altered intestinal function in patients with chronic heart failure
Sandek, A., Bauditz, J., Swidsinski, A., Buhner, S., Weber-Eibel, J., von Haehling, S., Schroedl, W., Karhausen, T., Doehner, W., Rauchhaus, M., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.016 · Cited by 661 · cited 1×
“Of interest, the patients in the studies by Sandek and Pasini had increased gut permeability as measured by the lactulose-mannitol test and the cellobiose sugar test [47,49] which fits well with reduced capacity for production of butyrate, the main energy source for colonocytes and critical for maintaining the gut bar…”
BackgroundWang, J., Thingholm, L. B., Skiecevičienė, J., Rausch, P., Kummen, M., Hov, J. R., Degenhardt, F., Heinsen, F.-A., Rühlemann, M. C., Szymczak, S., et al. (2016) · Nature Genetics · doi:10.1038/ng.3695 · Cited by 625
Self-citationγ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO
Koeth, R. A., Levison, B. S., Culley, M. K., Buffa, J. A., Wang, Z., Gregory, J. C., Org, E., Wu, Y., Li, L., Smith, J. D., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.006 · Cited by 546
Wang, Z., Bergeron, N., Levison, B. S., Li, X. S., Chiu, S., Jia, X., Koeth, R. A., Li, L., Wu, Y., Tang, W. H. W., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy799 · Cited by 496 · cited 3×
“For now, dietary interventions, including adherence to a Mediterranean diet [104] or discontinuation of dietary red meat [33], are more accessible ways of reducing TMAO levels and possibly, cardiovascular risk.”
BackgroundLi, X. S., Obeid, S., Klingenberg, R., Gencer, B., Mach, F., Räber, L., Windecker, S., Rodondi, N., Nanchen, D., Muller, O., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehw582 · Cited by 479
Trøseid, M., Ueland, T., Hov, J. R., Svardal, A., Gregersen, I., Dahl, C. P., Aakhus, S., Gude, E., Bjørndal, B., Halvorsen, B., et al. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12328 · Cited by 464
Self-citationChambers, E. S., Byrne, C. S., Morrison, D. J., Murphy, K. G., Preston, T., Tedford, C., Garcia-Perez, I., Fountana, S., Serrano-Contreras, J. I., Holmes, E., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318424 · Cited by 443
Pathogenic Gut Flora in Patients With Chronic Heart Failure
Pasini, E., Aquilani, R., Testa, C., Baiardi, P., Angioletti, S., Boschi, F., Verri, M., & Dioguardi, F. (2016) · JACC: Heart Failure · doi:10.1016/j.jchf.2015.10.009 · Cited by 436
Bile Acids and Metabolic Regulation
Staels, B., & Fonseca, V. A. (2009) · Diabetes Care · doi:10.2337/dc09-s355 · Cited by 415
Organ, C. L., Otsuka, H., Bhushan, S., Wang, Z., Bradley, J., Trivedi, R., Polhemus, D. J., Tang, W. H. W., Wu, Y., Hazen, S. L., et al. (2016) · Circulation: Heart Failure · doi:10.1161/circheartfailure.115.002314 · Cited by 382
A Proinflammatory Gut Microbiota Increases Systemic Inflammation and Accelerates Atherosclerosis
Brandsma, E., Kloosterhuis, N. J., Koster, M., Dekker, D. C., Gijbels, M. J. J., van der Velden, S., Ríos-Morales, M., van Faassen, M. J. R., Loreti, M. G., de Bruin, A., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.313234 · Cited by 375
Cui, X., Ye, L., Li, J., Jin, L., Wang, W., Li, S., Bao, M., Wu, S., Li, L., Geng, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18756-2 · Cited by 374
Loss of Gut Microbiota Alters Immune System Composition and Cripples Postinfarction Cardiac Repair
Tang, T. W. H., Chen, H.-C., Chen, C.-Y., Yen, C. Y. T., Lin, C.-J., Prajnamitra, R. P., Chen, L.-L., Ruan, S.-C., Lin, J.-H., Lin, P.-J., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.035235 · Cited by 348
Intestinal microbiota determine severity of myocardial infarction in rats
Lam, V., Su, J., Koprowski, S., Hsu, A., Tweddell, J. S., Rafiee, P., Gross, G. J., Salzman, N. H., & Baker, J. E. (2012) · The FASEB Journal · doi:10.1096/fj.11-197921 · Cited by 340
Gan, X. T., Ettinger, G., Huang, C. X., Burton, J. P., Haist, J. V., Rajapurohitam, V., Sidaway, J. E., Martin, G., Gloor, G. B., Swann, J. R., et al. (2014) · Circulation: Heart Failure · doi:10.1161/circheartfailure.113.000978 · Cited by 329
Microbiome 101: Studying, Analyzing, and Interpreting Gut Microbiome Data for Clinicians
Allaband, C., McDonald, D., Vázquez-Baeza, Y., Minich, J. J., Tripathi, A., Brenner, D. A., Loomba, R., Smarr, L., Sandborn, W. J., Schnabl, B., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.09.017 · Cited by 318
Yelin, I., Flett, K. B., Merakou, C., Mehrotra, P., Stam, J., Snesrud, E., Hinkle, M., Lesho, E., McGann, P., McAdam, A. J., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0626-9 · Cited by 315 · cited 1×
“Notably, genomic and epidemiological evidence of bacterial transmission from probiotic capsules to blood was recently reported in patients in intensive care units [84].”
BackgroundHeart Failure is Associated with Depletion of Core Intestinal Microbiota
Luedde, M., Winkler, T., Heinsen, F.-A., Rühlemann, M. C., Spehlmann, M. E., Bajrovic, A., Lieb, W., Franke, A., Ott, S. J., & Frey, N. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12155 · Cited by 312
Zhou, X., Li, J., Guo, J., Geng, B., Ji, W., Zhao, Q., Li, J., Liu, X., Liu, J., Guo, Z., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0441-4 · Cited by 302
Systemic inflammation in heart failure – The whys and wherefores
Yndestad, A., Kristian Damås, J., Øie, E., Ueland, T., Gullestad, L., & Aukrust, P. (2006) · Heart Failure Reviews · doi:10.1007/s10741-006-9196-2 · Cited by 294
Antibiotics promote inflammation through the translocation of native commensal colonic bacteria
Knoop, K. A., McDonald, K. G., Kulkarni, D. H., & Newberry, R. D. (2016) · Gut · doi:10.1136/gutjnl-2014-309059 · Cited by 274
New Approaches for Bacteriotherapy: Prebiotics, New-Generation Probiotics, and Synbiotics
Patel, R., & DuPont, H. L. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ177 · Cited by 267
Kamo, T., Akazawa, H., Suda, W., Saga-Kamo, A., Shimizu, Y., Yagi, H., Liu, Q., Nomura, S., Naito, A. T., Takeda, N., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0174099 · Cited by 265
Trimethylamine N-oxide and prognosis in acute heart failure
Suzuki, T., Heaney, L. M., Bhandari, S. S., Jones, D. J. L., & Ng, L. L. (2016) · Heart · doi:10.1136/heartjnl-2015-308826 · Cited by 253
Smits, L. P., Kootte, R. S., Levin, E., Prodan, A., Fuentes, S., Zoetendal, E. G., Wang, Z., Levison, B. S., Cleophas, M. C. P., Kemper, E. M., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008342 · Cited by 251
Gajarsa, J. J., & Kloner, R. A. (2011) · Heart Failure Reviews · doi:10.1007/s10741-010-9181-7 · Cited by 237
Large-Scale Analyses of Human Microbiomes Reveal Thousands of Small, Novel Genes
Sberro, H., Fremin, B. J., Zlitni, S., Edfors, F., Greenfield, N., Snyder, M. P., Pavlopoulos, G. A., Kyrpides, N. C., & Bhatt, A. S. (2019) · Cell · doi:10.1016/j.cell.2019.07.016 · Cited by 237
Andraws, R., Berger, J. S., & Brown, D. L. (2005) · JAMA · doi:10.1001/jama.293.21.2641 · Cited by 235
Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts
Kummen, M., Mayerhofer, C. C. K., Vestad, B., Broch, K., Awoyemi, A., Storm-Larsen, C., Ueland, T., Yndestad, A., Hov, J. R., & Trøseid, M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.057 · Cited by 227 · cited 2×
“Of relevance, the abundance of several members of the Lachnospiracea family correlated with soluble CD25, a marker of T cell activation, and depletion of the known butyrate producer Eubacterium Halli and increased plasma levels of soluble CD25 were associated with death or heart transplantation [45].”
BackgroundSelf-citationDysbiosis signatures of gut microbiota in coronary artery disease
Zhu, Q., Gao, R., Zhang, Y., Pan, D., Zhu, Y., Zhang, X., Yang, R., Jiang, R., Xu, Y., & Qin, H. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00070.2018 · Cited by 221
Plasma Lipopolysaccharide Is Closely Associated With Glycemic Control and Abdominal Obesity
Trøseid, M., Nestvold, T. K., Rudi, K., Thoresen, H., Nielsen, E. W., & Lappegård, K. T. (2013) · Diabetes Care · doi:10.2337/dc13-0451 · Cited by 217
Self-citationMendes-Soares, H., Raveh-Sadka, T., Azulay, S., Edens, K., Ben-Shlomo, Y., Cohen, Y., Ofek, T., Bachrach, D., Stevens, J., Colibaseanu, D., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.8102 · Cited by 212
Experimental design and quantitative analysis of microbial community multiomics
Mallick, H., Ma, S., Franzosa, E. A., Vatanen, T., Morgan, X. C., & Huttenhower, C. (2017) · Genome Biology · doi:10.1186/s13059-017-1359-z · Cited by 192
Costanza, A. C., Moscavitch, S. D., Faria Neto, H. C. C., & Mesquita, E. T. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.11.034 · Cited by 182
Meta'omic Analytic Techniques for Studying the Intestinal Microbiome
Morgan, X. C., & Huttenhower, C. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.049 · Cited by 173
Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure
Mayerhofer, C. C. K., Ueland, T., Broch, K., Vincent, R. P., Cross, G. F., Dahl, C. P., Aukrust, P., Gullestad, L., Hov, J. R., & Trøseid, M. (2017) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2017.06.007 · Cited by 170
Self-citationLi, X. S., Wang, Z., Cajka, T., Buffa, J. A., Nemet, I., Hurd, A. G., Gu, X., Skye, S. M., Roberts, A. B., Wu, Y., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99096 · Cited by 167
Fecal microbiota transplantation beyond Clostridioides difficile infections
Wortelboer, K., Nieuwdorp, M., & Herrema, H. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.05.066 · Cited by 163
Bile Acids Regulate Cardiovascular Function
Khurana, S., Raufman, J., & Pallone, T. L. (2011) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00272.x · Cited by 161
Jones, R. B., Zhu, X., Moan, E., Murff, H. J., Ness, R. M., Seidner, D. L., Sun, S., Yu, C., Dai, Q., Fodor, A. A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22408-4 · Cited by 150
Feng, Q., Liu, Z., Zhong, S., Li, R., Xia, H., Jie, Z., Wen, B., Chen, X., Yan, W., Fan, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep22525 · Cited by 149
Association Study of Gut Flora in Coronary Heart Disease through High-Throughput Sequencing
Cui, L., Zhao, T., Hu, H., Zhang, W., & Hua, X. (2017) · BioMed Research International · doi:10.1155/2017/3796359 · Cited by 145
Intestinal Microbial Metabolites Are Linked to Severity of Myocardial Infarction in Rats
Lam, V., Su, J., Hsu, A., Gross, G. J., Salzman, N. H., & Baker, J. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160840 · Cited by 143
Skagen, K., Trøseid, M., Ueland, T., Holm, S., Abbas, A., Gregersen, I., Kummen, M., Bjerkeli, V., Reier-Nilsen, F., Russell, D., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.01.033 · Cited by 139
Self-citationHayashi, T., Yamashita, T., Watanabe, H., Kami, K., Yoshida, N., Tabata, T., Emoto, T., Sasaki, N., Mizoguchi, T., Irino, Y., et al. (2018) · Circulation Journal · doi:10.1253/circj.cj-18-0468 · Cited by 139
Onal, E. M., Afşar, B., Covic, A. C., Vaziri, N. D., & Kanbay, M. (2018) · Hypertension Research · doi:10.1038/s41440-018-0144-z · Cited by 121
Selective Intestinal Decontamination in Advanced Chronic Heart Failure: A Pilot Trial
Conraads, V. M., Jorens, P. G., Clerck, L. S. D., van Saene, H. K., Ieven, M. M., Bosmans, J. M., Schuerwegh, A. J., Bridts, C. H., Wuyts, F. L., Stevens, W. J., et al. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2003.12.004 · Cited by 110
Li, X. S., Obeid, S. N., Wang, Z., Hazen, B. J., Li, L., Wu, Y., Hurd, A. G., Gu, X., Pratt, A., Levison, B. S., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz259 · Cited by 109
Low Fibre Intake is Associated with Gut Microbiota Alterations in Chronic Heart Failure
Mayerhofer, C. C. K., Kummen, M., Holm, K., Broch, K., Awoyemi, A., Vestad, B., Storm-Larsen, C., Seljeflot, I., Ueland, T., Bohov, P., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12596 · Cited by 107
Self-citationSelective decontamination of the digestive tract in cardiac surgical patients
Fox, M. A., Peterson, S. J., Fabri, B. M., et al. (1991) · Critical Care Medicine · doi:10.1097/00003246-199112000-00008 · Cited by 103
Ursodeoxycholic Acid in Patients With Chronic Heart Failure
von Haehling, S., Schefold, J. C., Jankowska, E. A., Springer, J., Vazir, A., Kalra, P. R., Sandek, A., Fauler, G., Stojaković, T., Trauner, M., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.10.880 · Cited by 101
The Gut and Intestinal Bacteria in Chronic Heart Failure
Sandek, A., Anker, S. D., & von Haehling, S. (2009) · Current Drug Metabolism · doi:10.2174/138920009787048374 · Cited by 91
Gut Microbiota and Cardiovascular Uremic Toxicities
Velasquez, M. T., Centron, P., Barrows, I. R., Dwivedi, R. S., & Raj, D. S. (2018) · Toxins · doi:10.3390/toxins10070287 · Cited by 85
Winkel, P., Hilden, J., Hansen, J. F., Kastrup, J., Kolmos, H. J., Kjøller, E., Jensen, G. B., Skoog, M., Lindschou, J., & Gluud, C. N. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.01.020 · Cited by 79
Prebiotics Modulate the Effects of Antibiotics on Gut Microbial Diversity and Functioning in Vitro
Johnson, L., Walton, G., Psichas, A., Frost, G. S., Gibson, G. R., & Barraclough, T. G. (2015) · Nutrients · doi:10.3390/nu7064480 · Cited by 75
Modesti, P. A., Vanni, S., Bertolozzi, I., Cecioni, I., Polidori, G., Paniccia, R., Bandinelli, B., Perna, A. M., Liguori, P., Boddi, M., et al. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.3.h976 · Cited by 67
Duration and life-stage of antibiotic use and risk of cardiovascular events in women
Heianza, Y., Zheng, Y., Ma, W., Rimm, E. B., Albert, C. M., Hu, F. B., Rexrode, K. M., Manson, J. E., & Qi, L. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz231 · Cited by 63
Mayerhofer, C. C. K., Awoyemi, A., Moscavitch, S. D., Lappegård, K. T., Hov, J. R., Aukrust, P., Hovland, A., Lorenzo, A. D., Halvorsen, S., Seljeflot, I., et al. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12332 · Cited by 57
Self-citationMetagenomic heterogeneity explains dual immune effects of endotoxins
Brix, S., Eriksen, C., Larsen, J. M., & Bisgaard, H. F. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.09.036 · Cited by 52
Bile Acids Have the Gall to Function as Hormones
Vallim, T. Q. D. A., & Edwards, P. A. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.005 · Cited by 44
McMillan, A., & Hazen, S. L. (2019) · Circulation · doi:10.1161/circulationaha.118.037384 · Cited by 40
Gut microbiota and acute coronary syndromes: ready for use in the emergency room?
Trøseid, M. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx005 · Cited by 32
Self-citationAwoyemi, A., Trøseid, M., Arnesen, H., Solheim, S., & Seljeflot, I. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.05.004 · Cited by 31
Self-citationTrøseid, M., Mayerhofer, C. C. K., Broch, K., Arora, S., Svardal, A. M., Hov, J. R., Andreassen, A. K., Gude, E., Karason, K., Dellgren, G., et al. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.06.003 · Cited by 24
Self-citationThe gut microbiome and transplantation: An amazon jungle
Madan, S., & Mehra, M. R. (2018) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2018.06.013 · Cited by 7
Potential Risk Associated with Direct Modulation of the Gut Flora in Patients with Heart Failure
He, Z., Wang, J., Chen, Y., et al. (2019) · ESC Heart Failure · doi:10.1002/ehf2.12403 · Cited by 5
Mayerhofer, C. C. K., Awoyemi, A., Hov, J. R., Trøseid, M., & Broch, K. (2019) · ESC Heart Failure · doi:10.1002/ehf2.12437 · Cited by 5
Self-citation
Cited by
Inflammation and cardiovascular disease: From mechanisms to therapeutics
Alfaddagh, A., Martin, S. S., Leucker, T. M., Michos, E. D., Blaha, M. J., Lowenstein, C. J., Jones, S. R., & Toth, P. P. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100130 · Cited by 473
Cardiovascular disease and cancer: shared risk factors and mechanisms
Wilcox, N. S., Amit, U., Reibel, J. B., Berlin, E., Howell, K., & Ky, B. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01017-x · Cited by 310
Large-Scale Analyses of Human Microbiomes Reveal Thousands of Small, Novel Genes
Sberro, H., Fremin, B. J., Zlitni, S., Edfors, F., Greenfield, N., Snyder, M. P., Pavlopoulos, G. A., Kyrpides, N. C., & Bhatt, A. S. (2019) · Cell · doi:10.1016/j.cell.2019.07.016 · Cited by 237
Brain-spleen axis in health and diseases: A review and future perspective
Wei, Y., Wang, T., Liao, L., Fan, X., Chang, L., & Hashimoto, K. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.02.008 · Cited by 134
Pontes, K. S. D. S., Guedes, M. R., Cunha, M. R. D., Mattos, S. D. S., Barreto Silva, M. I., Neves, M. F., Marques, B. C. A. A., & Klein, M. R. S. T. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.06.023 · Cited by 86
Metadata
- Authors
- Trøseid, M., Andersen, G. Ø., Broch, K., & Hov, J. R.
- Venue
- EBioMedicine
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 52
- Pages
- 102649
- ISSN
- 2352-3964 (ISSN-L)
- OpenAlex
- W3005887408
- Cited by
- 408
- References
- 107
- FWCI
- 13.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.